ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.94158
-0.29%
Brent Oil
81.355
0.68%
Bitcoin
68,235.73
0.72%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
02/06/202420:19PR Newswire (US)China Medical University Hospital (CMUH, Taiwan) Signs MOU with Malaysian International Medical University
02/06/202420:14PR Newswire (US)Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic Dermatitis
02/06/202420:00Business WireNissan démontre les progrès des services de mobilité autonomes sur la voie publique
02/06/202420:00PR Newswire (US)MSI Unveils New AI and Computing Platforms with 4th Gen AMD EPYC™ Processors at Computex 2024
02/06/202420:00PR Newswire (US)TECNO exhibits its diverse smartphone and AIoT ecosystem with futuristic AR and AI products at COMPUTEX Taipei 2024, with the concept "Smart of Creation"
02/06/202419:38GlobeNewswire Inc.Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III TrialNASDAQ:IMMPImmutep Ltd
02/06/202419:35CointelegraphCrypto exchanges see $3B Ethereum exit since ETF approvalsCOIN:BTCUSDBitcoin
02/06/202419:35Business WireWEBTOON Entertainment Announces Public Filing of Registration Statement for Proposed Initial Public Offering
02/06/202419:23GlobeNewswire Inc.Mesoblast Corporate Presentation at Investor ConferenceMSB.AX
02/06/202419:20Business WireDenodo ouvre un siège régional en Arabie saoudite pour répondre à la demande croissante en matière de gestion des données et d'intelligence artificielle
02/06/202419:15Business WireDenodo eröffnet im Königreich Saudi Arabien ME Regionalen Hauptsitz zwecks Abdeckung der steigenden Nachfrage nach Datenmanagement und KI
02/06/202419:08CointelegraphBitcoin post-halving run may reach $130K by September 2025COIN:BTCUSDBitcoin
02/06/202419:00The Daily HodlCrypto Whales Suddenly Gobble Up $112,000,000 Worth of Dogecoin Amid Bearish DOGE Sentiment: AnalystCOIN:FETUSDFetch
02/06/202419:00GlobeNewswire Inc.HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature MedicineNASDAQ:HCMHUTCHMED China Limited
02/06/202419:00PR Newswire (US)Darren Bishop Joins TradeFlow Capital Management as Head of Strategic Partnerships (UK/Europe)
02/06/202418:54PR Newswire (US)BLVD United Signs MOU with MeDoDo Coin: Pioneering a New Era in Fan Engagement and Biotech Innovation
02/06/202418:46CointelegraphMatter Labs drops ZK trademark applications after industry backlashCOIN:BTCUSDBitcoin
02/06/202418:46Business WireDenodo integriert NVIDIA NIM Inference Microservices für die Beschleunigung und Optimierung von KI-Funktionen für Unternehmen
02/06/202418:39Business WireDenodo intègre les microservices d'inférence NIM de NVIDIA pour accélérer et optimiser les capacités d'IA pour les entreprises
02/06/202418:00Business WireOther World Computing Introduces Intel Thunderbolt Share for the Thunderbolt Go Dock
02/06/202418:00GlobeNewswire Inc.Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
02/06/202418:00PR Newswire (US)Cody Allison Named Mid-South Super Lawyer Again; Featured Attorney in Mid-South Super Lawyers Magazine
02/06/202417:54PR Newswire (US)William David Art Gallery Opens in Las Vegas with Captivating Collections: The Royal Family and Serial Killers
02/06/202417:54PR Newswire (Canada)La Chine et la Corée du Sud renforcent leurs liens économiques à l'occasion de la conférence promotionnelle de la deuxième édition de la CISCE
02/06/202417:43GlobeNewswire Inc.Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer ImagingTLX.AX
02/06/202417:20GlobeNewswire Inc.Biognosys lanza Spectronaut 19 y presenta los avances de sus plataformas de investigación en la Conferencia Anual de la ASMS 2024
02/06/202417:20GlobeNewswire Inc.Biognosys lance Spectronaut 19 et présente les avancées dans ses plateformes de recherche lors de la conférence annuelle de l’ASMS 2024
02/06/202417:20GlobeNewswire Inc.Biognosys bringt Spectronaut 19 auf den Markt und präsentiert die Fortschritte seiner Forschungsplattformen auf der Jahreskonferenz der ASMS 2024
02/06/202417:20GlobeNewswire Inc.Biognosys lancia Spectronaut 19 e presenta i progressi delle sue piattaforme di ricerca alla conferenza annuale ASMS 2024
02/06/202417:15PR Newswire (US)Fast Guard Service Shares Their Experience with Local Business Owner as the Best Security Guard Company in California

Su Consulta Reciente

NYSE
NKE
Nike
NYSE
AXP
American Express
NASDAQ
TSLA
Tesla
FX
EURUSD
Euro vs US Dollar
NYSE
VZ
Verizon Communications
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
ADDYY
Adidas (QX)
CCOM
US500
US 500
NASDAQ
AMZN
Amazon.com
CCOM
SILVER
SILVER
NYSE
CVX
Chevron
NYSE
MCD
McDonalds
CCOM
OILBRENT
Brent Oil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados